• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纯合子和杂合子核纤层蛋白A p.R582C突变:同一家族中的不同脂肪营养不良表型。

Homozygous and Heterozygous Nuclear Lamin A p.R582C Mutation: Different Lipodystrophic Phenotypes in the Same Kindred.

作者信息

Montenegro Renan Magalhães, Costa-Riquetto Aline Dantas, Fernandes Virgínia Oliveira, Montenegro Ana Paula Dias Rangel, de Santana Lucas Santos, Jorge Alexander Augusto de Lima, Karbage Lia Beatriz de Azevedo Souza, Aguiar Lindenberg Barbosa, Carvalho Francisco Herlânio Costa, Teles Milena Gurgel, d'Alva Catarina Brasil

机构信息

Brazilian Group for the Study of Inherited and Acquired Lipodystrophies, Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza, Brazil.

Monogenic Diabetes Group, Genetic Endocrinology Unit (LIM25), Hospital das Clinicas da Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.

出版信息

Front Endocrinol (Lausanne). 2018 Aug 20;9:458. doi: 10.3389/fendo.2018.00458. eCollection 2018.

DOI:10.3389/fendo.2018.00458
PMID:30177912
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6110164/
Abstract

Dunnigan-type familial partial lipodystrophy (FPLD2) is a rare autosomal dominant disease caused by heterozygous mutations in the gene that results in regional loss of subcutaneous adipose tissue with onset in puberty. However, a generalized lipodystrophy phenotype has also been associated with heterozygous mutations in this gene, demonstrating the noticeable phenotypic heterogeneity of this disease. We report and describe clinical and metabolic features of four patients from the same family with the p.R582C mutation, three homozygous and one in the heterozygous state that present with three distinct lipodystrophic phenotypes. Case description: The proband was a 12-year-old girl who developed severe subcutaneous fat atrophy in limbs and abdomen followed by a remarkable dorsocervical fat accumulation in adulthood along with diabetes at age 23. The proband's sister was a phenotypically normal girl who developed hypertriglyceridemia at age 8, progressive features of partial lipodystrophy at age 11, and diabetes at age 22. The proband's mother was first examined at age 32, presenting diabetes and a severe generalized lipodystrophic phenotype; she developed kidney failure at age 41 and died due to diabetic complications. The proband's father was a 50-year-old man with abdominal fat concentration that was initially considered phenotypically normal. Massively parallel sequencing using a platform of genes related to genetic lipodystrophies, followed by Sanger sequencing, revealed the transversion c.1744C>T at exon 11 of the gene (p.R582C) in the homozygous (mother and daughters) and heterozygous (father) states. We documented three distinct phenotypes of the homozygous and heterozygous p. R582C mutation in the same kindred, illustrating that FPLD2 linked to mutations in this gene is a disease of great clinical heterogeneity, possibly due to associated environmental or genetic factors.

摘要

邓尼根型家族性部分脂肪营养不良(FPLD2)是一种罕见的常染色体显性疾病,由该基因的杂合突变引起,导致青春期开始时皮下脂肪组织区域性缺失。然而,该基因的杂合突变也与全身性脂肪营养不良表型相关,表明这种疾病具有显著的表型异质性。我们报告并描述了来自同一家族的四名携带p.R582C突变患者的临床和代谢特征,其中三名纯合子和一名杂合子患者呈现出三种不同的脂肪营养不良表型。病例描述:先证者是一名12岁女孩,四肢和腹部出现严重的皮下脂肪萎缩,成年后颈背部脂肪显著堆积,并在23岁时患上糖尿病。先证者的妹妹是一名表型正常的女孩,8岁时出现高甘油三酯血症,11岁时出现部分脂肪营养不良的进行性特征,22岁时患上糖尿病。先证者的母亲首次检查时32岁,患有糖尿病和严重的全身性脂肪营养不良表型;她在41岁时出现肾衰竭,因糖尿病并发症死亡。先证者的父亲是一名50岁男性,腹部脂肪集中,最初被认为表型正常。使用与遗传性脂肪营养不良相关的基因平台进行大规模平行测序,随后进行桑格测序,发现在该基因第11外显子处存在纯合(母亲和女儿)和杂合(父亲)状态的颠换c.1744C>T(p.R582C)。我们记录了同一家族中纯合和杂合p.R582C突变的三种不同表型,说明与该基因突变相关的FPLD2是一种临床异质性很大的疾病,可能是由于相关的环境或遗传因素所致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685c/6110164/c4fb978ef3bb/fendo-09-00458-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685c/6110164/75a6532062cc/fendo-09-00458-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685c/6110164/e6af2d2e1687/fendo-09-00458-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685c/6110164/e1981fc10be2/fendo-09-00458-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685c/6110164/d643984b5bc0/fendo-09-00458-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685c/6110164/64adcd849aaf/fendo-09-00458-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685c/6110164/c4fb978ef3bb/fendo-09-00458-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685c/6110164/75a6532062cc/fendo-09-00458-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685c/6110164/e6af2d2e1687/fendo-09-00458-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685c/6110164/e1981fc10be2/fendo-09-00458-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685c/6110164/d643984b5bc0/fendo-09-00458-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685c/6110164/64adcd849aaf/fendo-09-00458-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685c/6110164/c4fb978ef3bb/fendo-09-00458-g0006.jpg

相似文献

1
Homozygous and Heterozygous Nuclear Lamin A p.R582C Mutation: Different Lipodystrophic Phenotypes in the Same Kindred.纯合子和杂合子核纤层蛋白A p.R582C突变:同一家族中的不同脂肪营养不良表型。
Front Endocrinol (Lausanne). 2018 Aug 20;9:458. doi: 10.3389/fendo.2018.00458. eCollection 2018.
2
Phenotypic diversity in patients with lipodystrophy associated with LMNA mutations.伴有 LMNA 突变的脂肪营养不良患者的表型多样性。
Eur J Endocrinol. 2012 Sep;167(3):423-31. doi: 10.1530/EJE-12-0268. Epub 2012 Jun 14.
3
Homozygous p.R582H pathogenic variant reveals increasing effect on the severity of fat loss in lipodystrophy.纯合子p.R582H致病变异揭示其对脂肪营养不良中脂肪流失严重程度的影响不断增加。
Clin Diabetes Endocrinol. 2020 Jul 14;6:13. doi: 10.1186/s40842-020-00100-9. eCollection 2020.
4
A LMNA splicing mutation in two sisters with severe Dunnigan-type familial partial lipodystrophy type 2.两名患有严重2型邓尼根型家族性部分脂肪营养不良的姐妹中存在LMNA剪接突变。
J Clin Endocrinol Metab. 2006 Jul;91(7):2689-95. doi: 10.1210/jc.2005-2746. Epub 2006 Apr 24.
5
Monogenic forms of lipodystrophic syndromes: diagnosis, detection, and practical management considerations from clinical cases.单基因脂肪代谢障碍综合征:从临床病例看诊断、检测及实际管理的注意事项。
Curr Med Res Opin. 2019 Mar;35(3):543-552. doi: 10.1080/03007995.2018.1533459. Epub 2018 Nov 9.
6
Atypical generalized lipoatrophy and severe insulin resistance due to a heterozygous LMNA p.T10I mutation.因杂合性LMNA基因p.T10I突变导致的非典型全身性脂肪萎缩和严重胰岛素抵抗。
Arq Bras Endocrinol Metabol. 2008 Nov;52(8):1252-6. doi: 10.1590/s0004-27302008000800008.
7
Juvenile-onset generalized lipodystrophy due to a novel heterozygous missense LMNA mutation affecting lamin C.由于一种影响核纤层蛋白C的新型杂合错义LMNA突变导致的青少年型全身性脂肪营养不良。
Am J Med Genet A. 2017 Sep;173(9):2517-2521. doi: 10.1002/ajmg.a.38341. Epub 2017 Jul 7.
8
A novel phenotypic expression associated with a new mutation in LMNA gene, characterized by partial lipodystrophy, insulin resistance, aortic stenosis and hypertrophic cardiomyopathy.一种与LMNA基因新突变相关的新型表型表达,其特征为部分脂肪营养不良、胰岛素抵抗、主动脉狭窄和肥厚型心肌病。
Clin Endocrinol (Oxf). 2008 Jul;69(1):61-8. doi: 10.1111/j.1365-2265.2007.03146.x. Epub 2008 Jul 1.
9
Regional Body Fat Changes and Metabolic Complications in Children With Dunnigan Lipodystrophy-Causing LMNA Variants.Dunnigan 型脂肪营养不良相关 LMNA 变异所致儿童区域性体脂变化与代谢并发症。
J Clin Endocrinol Metab. 2019 Apr 1;104(4):1099-1108. doi: 10.1210/jc.2018-01922.
10
High-throughput Second-generation Sequencing Technology Assisted Diagnosis of Familial Partial Lipodystrophy (Type 2 Kobberling-Dunnigan Syndrome): A Case Report.高通量第二代测序技术辅助诊断家族性部分性脂肪营养不良(2 型科伯林-邓尼根综合征):病例报告。
Comb Chem High Throughput Screen. 2024;27(2):346-351. doi: 10.2174/1386207326666230523112454.

引用本文的文献

1
Lipodystrophic Laminopathies: From Dunnigan Disease to Progeroid Syndromes.脂肪营养不良性层板病:从邓尼根病到早老综合征。
Int J Mol Sci. 2024 Aug 28;25(17):9324. doi: 10.3390/ijms25179324.
2
: Unveiling the Function of a Novel Gene Associated with Hereditary Myopathy.揭示与遗传性肌肉病相关的新基因的功能。
Cells. 2024 Sep 8;13(17):1504. doi: 10.3390/cells13171504.
3
Anthropometric measurements as a key diagnostic tool for familial partial lipodystrophy in women.人体测量作为女性家族性部分脂肪营养不良的关键诊断工具。

本文引用的文献

1
A Novel Generalized Lipodystrophy-Associated Progeroid Syndrome Due to Recurrent Heterozygous LMNA p.T10I Mutation.一种新型的广义脂肪营养不良相关早老综合征与 LMNA p.T10I 错义突变的反复杂合性相关。
J Clin Endocrinol Metab. 2018 Mar 1;103(3):1005-1014. doi: 10.1210/jc.2017-02078.
2
Lipodystrophic laminopathy: Lamin A mutation relaxes chromatin architecture to impair adipogenesis.脂肪营养不良性核纤层病:核纤层蛋白A突变使染色质结构松弛,从而损害脂肪生成。
J Cell Biol. 2017 Sep 4;216(9):2607-2610. doi: 10.1083/jcb.201707090. Epub 2017 Aug 15.
3
A lipodystrophy-causing lamin A mutant alters conformation and epigenetic regulation of the anti-adipogenic locus.
Diabetol Metab Syndr. 2024 Sep 4;16(1):216. doi: 10.1186/s13098-024-01413-w.
4
Comprehensive analysis of morbidity and mortality patterns in familial partial lipodystrophy patients: insights from a population study.家族性部分性脂肪营养不良患者发病率和死亡率模式的综合分析:一项人群研究的启示。
Front Endocrinol (Lausanne). 2024 Jun 3;15:1359211. doi: 10.3389/fendo.2024.1359211. eCollection 2024.
5
Deciphering the Clinical Presentations in LMNA-related Lipodystrophy: Report of 115 Cases and a Systematic Review.解读与LMNA相关脂肪营养不良的临床表现:115例报告及系统评价
J Clin Endocrinol Metab. 2024 Feb 20;109(3):e1204-e1224. doi: 10.1210/clinem/dgad606.
6
Clinical Spectrum of -Associated Type 2 Familial Partial Lipodystrophy: A Systematic Review.与 2 型家族性部分脂肪营养不良相关的临床谱:系统评价。
Cells. 2023 Feb 24;12(5):725. doi: 10.3390/cells12050725.
7
Phenotypic Differences Among Familial Partial Lipodystrophy Due to or Variants.由……或变体导致的家族性部分脂肪营养不良的表型差异。
J Endocr Soc. 2022 Oct 11;6(12):bvac155. doi: 10.1210/jendso/bvac155. eCollection 2022 Oct 26.
8
In Silico and In Vivo Analysis of Amino Acid Substitutions That Cause Laminopathies.氨基酸替换导致层粘连蛋白病的计算机模拟和体内分析。
Int J Mol Sci. 2021 Oct 18;22(20):11226. doi: 10.3390/ijms222011226.
9
Partial Lipodystrophy and LMNA p.R545H Variant.部分脂肪营养不良与LMNA基因p.R545H变异体
J Clin Med. 2021 Mar 9;10(5):1142. doi: 10.3390/jcm10051142.
10
Magnetic resonance spectroscopy to assess hepatic steatosis in patients with lipodystrophy.磁共振波谱分析评估脂肪营养不良患者的肝脂肪变性。
Turk J Gastroenterol. 2020 Aug;31(8):588-595. doi: 10.5152/tjg.2020.19114.
一种导致脂肪营养不良的核纤层蛋白A突变体改变了抗脂肪生成位点的构象和表观遗传调控。
J Cell Biol. 2017 Sep 4;216(9):2731-2743. doi: 10.1083/jcb.201701043. Epub 2017 Jul 27.
4
PDX1 -MODY and dorsal pancreatic agenesis: New phenotype of a rare disease.PDX1-MODY 和背侧胰发育不全:一种罕见疾病的新表型。
Clin Genet. 2018 Feb;93(2):382-386. doi: 10.1111/cge.13044. Epub 2017 Jul 19.
5
Metabolic and cardiac phenotype characterization in 37 atypical Dunnigan patients with nonfarnesylated mutated prelamin A.37例非法尼基化突变前层粘连蛋白A的非典型邓尼根患者的代谢和心脏表型特征
Am Heart J. 2015 Apr;169(4):587-93. doi: 10.1016/j.ahj.2014.12.021. Epub 2015 Jan 7.
6
Lamins: nuclear intermediate filament proteins with fundamental functions in nuclear mechanics and genome regulation.核纤层蛋白:细胞核力学和基因组调控的基本功能的核中间丝蛋白。
Annu Rev Biochem. 2015;84:131-64. doi: 10.1146/annurev-biochem-060614-034115. Epub 2015 Feb 26.
7
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.序列变异解读的标准与指南:美国医学遗传学与基因组学学会和分子病理学协会的联合共识推荐
Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.
8
Phenotypic diversity in patients with lipodystrophy associated with LMNA mutations.伴有 LMNA 突变的脂肪营养不良患者的表型多样性。
Eur J Endocrinol. 2012 Sep;167(3):423-31. doi: 10.1530/EJE-12-0268. Epub 2012 Jun 14.
9
A homozygous mutation of prelamin-A preventing its farnesylation and maturation leads to a severe lipodystrophic phenotype: new insights into the pathogenicity of nonfarnesylated prelamin-A.早老素-A 的一个导致其不能法尼化和成熟的纯合突变导致严重的脂肪营养不良表型:对非法尼化早老素-A 致病性的新认识。
J Clin Endocrinol Metab. 2011 May;96(5):E856-62. doi: 10.1210/jc.2010-2234. Epub 2011 Feb 23.
10
miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells.miR-335 调控人骨髓间充质干细胞的增殖、迁移和分化。
Cell Death Differ. 2011 Jun;18(6):985-95. doi: 10.1038/cdd.2010.167. Epub 2010 Dec 17.